159724-47-7

Upstream product

• 40655-37-6 N-(4-(tert-butyl)-2-nitrophenyl)acetamide 
• 769-92-6 4-tert-Butylaniline 
• 591-18-4 1-Bromo-3-iodobenzene 
• 6310-19-6 4-tert-butyl-2-nitroaniline 

Downstream Products

• 159725-64-1 C₁₆H₁₉BrN₂ 
• 159725-23-2 1-(3-bromophenyl)-5-tert-butyl-1H-benzo[d]imidazole 
• 1287738-87-7 3'-(5-tert-butyl-1H-benzo[d]imidazol-1-yl)biphenyl-2-carbonitrile 

Relevant academic research and scientific papers

SUBSITITUTED BENZIMIDAZOLES

This invention relates to novel substituted benzimidazoles and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound that modulates theGABAA receptor. This invention also provides novel intermediates for the preparation of the compounds of the invention, and salts thereof.

Benzimidazole compounds

The present patent application discloses compounds having the formula STR1 or a pharmaceutically acceptable salt thereof wherein R 3, R 4, R 6 and R 7 each have the meanings set forth in the specification.The compounds are useful for the treatment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.

Benzimidazole useful in the treatment of central nervous system disorders

Compounds having the formula: or a pharmaceutically acceptable salt thereof, wherein, R3 is are useful for the treatment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.